In January 2023, Agilent Technologies recently acquired Avida Biomed, a startup life science company that develops high-performance target-enrichment techniques with unique capabilities for clinical ...

(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing novel therapies targeting hypoxia and mitochondrial dysfunction, today highlighted the historical and scientific ...

Therefore, the quantity of ammonium nitrogen is a routine examination for the monitoring of surface water and wastewater in China. The development of a sensitive and selective analytical method for ...